Market Blogs

Sun Pharma launches generic Glumetza

Sun Pharma enters in a competitive Metformin market in which Lupin enjoyed a 180-day exclusivity in 2016, while Teva has also been present. The drug size has shrunk by 63% since Sun Pharma received the approval in 2016.


Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.